| 1 |
28702823 | Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis. | 2017 Oct |
3 |
| 2 |
23124518 | Etoposide sensitizes neuroblastoma cells expressing caspase 8 to TRAIL. | 2012 Jun 21 |
7 |
| 3 |
21514380 | Suppression of multidrug resistance by treatment with TRAIL in human ovarian and breast cancer cells with high level of c-Myc. | 2011 Jul |
2 |
| 4 |
22120628 | p53-Independent up-regulation of a TRAIL receptor DR5 by proteasome inhibitors: a mechanism for proteasome inhibitor-enhanced TRAIL-induced apoptosis. | 2011 Dec 9 |
1 |
| 5 |
20416058 | Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL. | 2010 Apr 23 |
3 |
| 6 |
20877355 | Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours. | 2010 Oct 26 |
1 |
| 7 |
19834905 | Identification of molecular targets for selective elimination of TRAIL-resistant leukemia cells. From spots to in vitro assays using TOP15 charts. | 2009 Nov |
2 |
| 8 |
19843632 | Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells. | 2009 Nov |
1 |
| 9 |
17431117 | Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1. | 2007 Apr |
1 |
| 10 |
17441316 | Combination of gamma-interferon with TRAIL and cisplatin or etoposide induces apoptosis in human neuroblastoma cell line SH-SY5Y. | 2007 Mar |
2 |
| 11 |
17881904 | Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4. | 2007 Sep |
1 |
| 12 |
16863850 | Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma. | 2006 Aug |
2 |
| 13 |
16923369 | [Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells]. | 2006 Aug |
1 |
| 14 |
17097066 | Acquired TRAIL resistance in human breast cancer cells are caused by the sustained cFLIP(L) and XIAP protein levels and ERK activation. | 2006 Dec 29 |
1 |
| 15 |
15615731 | Bid mediates apoptotic synergy between tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and DNA damage. | 2005 Apr 1 |
2 |
| 16 |
15368357 | PI-3-kinase/NF-kappaB mediated response of Jurkat T leukemic cells to two different chemotherapeutic drugs, etoposide and TRAIL. | 2004 Oct 1 |
2 |
| 17 |
15634660 | Camptothecin- and etoposide-induced apoptosis in human leukemia cells is independent of cell death receptor-3 and -4 aggregation but accelerates tumor necrosis factor-related apoptosis-inducing ligand-mediated cell death. | 2004 Dec |
1 |
| 18 |
12618199 | Etoposide-mediated sensitization of squamous cell carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced loss in mitochondrial membrane potential. | 2003 Apr |
6 |
| 19 |
12838325 | Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. | 2003 Jul 7 |
2 |
| 20 |
14500373 | Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. | 2003 Sep 1 |
3 |
| 21 |
14519653 | Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells. | 2003 Sep 15 |
1 |
| 22 |
14601052 | Selective and nonselective toxicity of TRAIL/Apo2L combined with chemotherapy in human bone tumour cells vs. normal human cells. | 2003 Dec 20 |
4 |
| 23 |
14655759 | TRAIL triggers apoptosis in human malignant glioma cells through extrinsic and intrinsic pathways. | 2003 Oct |
1 |
| 24 |
11803469 | TRAIL and inhibitors of apoptosis are opposing determinants for NF-kappaB-dependent, genotoxin-induced apoptosis of cancer cells. | 2002 Jan 10 |
1 |
| 25 |
11992538 | Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. | 2002 Jun 1 |
6 |
| 26 |
12014636 | Chemosensitization of T-47D breast carcinoma cells to TRAIL and Fas receptor-induced killing. | 2002 Mar-Apr |
1 |
| 27 |
12127563 | Anticancer-drug-induced apoptotic cell death in leukemia cells is associated with proteolysis of beta-catenin. | 2002 Sep |
1 |
| 28 |
11472983 | Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines. | 2001 Jul |
1 |
| 29 |
10706092 | Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. | 2000 Feb 15 |
2 |
| 30 |
11090076 | Antileukemic drugs increase death receptor 5 levels and enhance Apo-2L-induced apoptosis of human acute leukemia cells. | 2000 Dec 1 |
2 |